Cargando…

Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study

BACKGROUND: Previous research has suggested a link between antidepressants use and the development of cerebrovascular events, but there has never been any study investigating the risk of stroke in obsessive-compulsive disorder (OCD) patients treated with a selective serotonin reuptake inhibitor (SSR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Che-Sheng, Chou, Po-Han, Lin, Ching-Heng, Cheng, Chin, Tsai, Chia-Jui, Lan, Tsuo-Hung, Huang, Min-Wei, Nestadt, Gerald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017574/ https://www.ncbi.nlm.nih.gov/pubmed/27612144 http://dx.doi.org/10.1371/journal.pone.0162239

Ejemplares similares

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Shahini, Najmeh, et al.
Publicado: (2021)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder
por: Vakili, Yaghoob, et al.
Publicado: (2015)

Genetics of obsessive-compulsive disorder
por: Purty, Abhishek, et al.
Publicado: (2019)

Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder
por: Arrojo-Romero, Manuel, et al.
Publicado: (2013)

Adjunct Triptorelin in the Treatment of Obsessive-Compulsive Disorder in Clients Receiving Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Nikzad, Faezeh, et al.
Publicado: (2021)

Adjunctive therapeutic strategies in Obsessive-Compulsive Disorder resistant to serotonin reuptake inhibitors: a literature review
por: Regueira, P., et al.
Publicado: (2022)

Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis
por: Sassano-Higgins, Sean A., et al.
Publicado: (2015)

Cognitive Function before and during Treatment with Selective Serotonin Reuptake Inhibitors in Patients with Depression or Obsessive-Compulsive Disorder
por: Sayyah, Mehdi, et al.
Publicado: (2016)

Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial
por: Khalkhali, Mohammadrasoul, et al.
Publicado: (2016)

The effects of selective serotonin reuptake inhibitors on brain functional networks during goal-directed planning in obsessive–compulsive disorder
por: Kim, Minah, et al.
Publicado: (2020)

Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial
por: Humble, Mats B., et al.
Publicado: (2016)

The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis
por: Kotapati, Vijaya Padma, et al.
Publicado: (2019)

Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
por: Xu, Jiao, et al.
Publicado: (2021)

Cognitive-Behavioral Therapy Versus Transcranial Direct Current Stimulation for Augmenting Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder Patients
por: Dadashi, Mohsen, et al.
Publicado: (2020)

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder
por: Fineberg, Naomi A., et al.
Publicado: (2018)

Immune-Related Comorbidities in Childhood-Onset Obsessive Compulsive Disorder: Lifetime Prevalence in the Obsessive Compulsive Disorder Collaborative Genetics Association Study
por: Westwell-Roper, Clara, et al.
Publicado: (2019)

Serotonin transporter gene polymorphisms & obsessive-compulsive disorder
por: Nicolini, Humberto
Publicado: (2010)

Contamination-related behaviors, obsessions, and compulsions during the COVID-19 pandemic in a United States population sample
por: Samuels, Jack, et al.
Publicado: (2021)

Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series
por: Fornaro, Michele
Publicado: (2011)

Validating a dimension of doubt in decision-making: A proposed endophenotype for obsessive-compulsive disorder
por: Marton, Tanya, et al.
Publicado: (2019)

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials
por: Dold, Markus, et al.
Publicado: (2015)

Efficacy of inhibitory learning theory-based exposure and response prevention and selective serotonin reuptake inhibitor in obsessive-compulsive disorder management: A treatment comparison
por: Samantaray, Narendra Nath, et al.
Publicado: (2018)

PS01. Influence of age of onset on serotonin transporters of obsessive-compulsive
por: Lee, Junhee, et al.
Publicado: (2016)

Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2019)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Prevalence of Obsessive-Compulsive Spectrum Disorders in Obsessive-Compulsive Disorder
por: Siddiqui, Mohammad Aleem, et al.
Publicado: (2018)

Serotonin Modulates the Correlations between Obsessive-compulsive Trait and Heart Rate Variability in Normal Healthy Subjects: A SPECT Study with [(123)I]ADAM and Heart Rate Variability Measurement
por: Kuo, Che Yu, et al.
Publicado: (2022)

SUCCESSFUL TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER WITH ZIMELIDINE, A SEROTONIN RE-UPTAKE INHIBITOR
por: Prasad, Ashoka
Publicado: (1983)

Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder
por: Zhang, Kai, et al.
Publicado: (2019)

Author Correction: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2020)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2017)

Perceived Stress in Obsessive–Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms
por: Morgado, P., et al.
Publicado: (2013)

Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study
por: Humble, Mats B, et al.
Publicado: (2013)

Improvement of Post Stroke Echolalia after Using Selective Serotonin Reuptake Inhibitors
por: Bae, Heewon, et al.
Publicado: (2019)

Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline
por: Lissemore, Jennifer I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vngjbfm03s3q8atqju8n1vhkhc